The precision oncology platform is based on research by Duke and Hubrecht Institute faculty and the cash will fund technology development and clinical studies.

The fund will invest in companies linked to École Polytechnique, including spinouts, alumni-founded startups or businesses incubated by the school.

GV contributed to the precision oncology platform developer's series A round, which will fund technology development and clinical studies.

Novo and Sanofi Ventures both participated in a series A round for the neurodegenrative disease drug developer, which is led by EIRs at Novo Seeds.

The musculoskeletal healthcare provider has added cash from Intermountain Healthcare, Ascension Ventures and Echo Health Ventures to a round now surpassing $50m.

NTT Docomo Ventures and 31Ventures returned for the smart key system provider’s $15.8m round, which included Kokuyo, NN Corporate Capital and JR East Start Up.

Colopl, Fuji Media, HTG, Kosei Pharma, Mori Trust, Nomura, SBS and Vector all backed a $20.5m round for the Askul and Ricoh-backed lending and borrowing marketplace..

VIB and V-Bio Ventures have both participated in a series A round for Muna Therapeutics, the result of a merger of two recent spinouts.

The M12-backed workforce management software developer has increased its overall funding to $115m through a series C round led by SoftBank.

Thai Union, BRF, CJ CheilJedang, Strauss Group and Cargill backed the cultured meat developer's series B round, which took the overall funding raised by the company to $118m.